Nexalin Technology, Inc. Common Stock
NXL Real Time Price USDRecent trades of NXL by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NXL's directors and management
Government lobbying spending instances
-
$20,000 Jan 20, 2025 Issue: Health Issues Defense Veterans
-
$20,000 Oct 20, 2024 Issue: Veterans Defense Health Issues
-
$20,000 Jul 18, 2024 Issue: Veterans Defense Health Issues
-
$20,000 Apr 21, 2024 Issue: Veterans Defense Health Issues
-
$30,000 Jan 20, 2024 Issue: Veterans Defense Health Issues
-
$20,000 Oct 20, 2023 Issue: Veterans Defense Health Issues
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Transcranial alternating current dynamic frequency stimulation (tacs) method for alzheimers and dementia Jun. 18, 2024
-
Patent Title: Transcranial alternating current dynamic frequency stimulation method for anxiety, depression, and insomnia (adi) Apr. 02, 2024
-
Patent Title: Transcranial alternating current dynamic frequency stimulation (tacs) system Jan. 16, 2024
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of NXL in WallStreetBets Daily Discussion
Recent insights relating to NXL
Recent picks made for NXL stock on CNBC
ETFs with the largest estimated holdings in NXL
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view NXL Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.